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Dopachrome tautomcrase (DT) (EC 5.323) is H melanocyte-specific. membrane-associated, heat-labile, non-dialyzablc, protcase-sensitive factor 
which ca~alyzcs the isomeric rcarrunycment ofdopachrome to 5.6.dihydroxyindole -2-curboxylic acid (DHICA). ;ipparently through a tautomcriza- 
lion reaclion. Metal ions such as Cu. Ni. Co, Zn, Mn. Ca, Al. and Fe cun also catalyze the dopachrome/DHICA isomerimtion. How is the reaction 
regulated in vivo? An altractive possibility would be thilt DT isa metullocnzymc, Here we present cvidcnce that this may indeed be thccuse. Purified 
preparations of DT and tyrosinuse. obuincd kom Cloudman S9l mouse melanoma cells. wcrc assuycd in the presence of a variety ofmctal chelators 
including EDTA (predominantly CI and Mgj. EGTA (predominantly 0). phcnylthiourca (PTIJ) (predominantly Cu), ?,?-dipyridyl (prcdomi- 
nantly Fe): I,IO-phenunthrolinc (predominantly Fc), and 2,3-dihydroxybenzoic a id (predominantly Fe). In addition, DT activity was assayed in 
lhe prcscncc of two non-cheluting structural analogs of I.lO-phenanthroline. Results were as follows: (i) iron chelators inhibited DT activity with 
no C~~CIS on tyrosinasc activity; (ii) inhibition by the chelators was rcversiblc with Ihe uddilion of ferrous iron: (iii) I.IO-phenenthrolinc 
pre-complcxcd to ferrous iron was not inhibitory to DT: (iv) non-chelating analogs of phenanthroline were not inhibitory to DT; (v) PTU was 
inhibitory to tyrosinase but not DT; (vij Cu” and My” chelators had little cffcct on cithcr enzyme activity. Finally, studies with glycosylution 
inhibitors, glycosylasc enzymes. and immobilized Icctins. indicalcd that DT is a glycoprotcin. The results uggest that DT is a metal-containing 
glycosylatcd cnzymc. possibly with ferrous iron at iis catalytic center. 
Dopachrome tautomerese: Fc-Cilycoprotcin; Melunogenesis 
1. INTRODUCTION 
In 1980 it was reported for the first time that a do- 
pachrome conversion factor (DCF) present in 2 differ- 
ent mouse melanomas and a hamster melanoma was 
capable of converting orange-red opachrome into a 
colorless compound [l-2]. Dopachrome containing a 
14C-!abelled carboxyl group was prepared, and it was 
noted that while DCF completely decolorized do- 
pachrome within IO min. during that same period 90% 
of the “C-labelled carboxy! groups remained intact. 
From this observation, it was surmised that DCF con- 
verted dopachrome to DHICA (5.6-dihydroxyindole-2- 
carboxylic acid). This was later verified by Korner and 
Getting who identified DHICA as the pruduct of the 
reaction through the use of mass spectroscopy and nu- 
clear magnetic resonance [3]. Soon after, a number of 
laboratories reported that dopachrome spontaneously 
loses its carboxy! group to from DHI unless an isomeric 
rearrangement to DHICA is catalyzed, either by metal 
ions or by the proteinaceous. melanocyte-specific DCF 
of Korner and Pawelek [4-g]. There is now general 
*Pw,wnr addrw: Department of Dermaiolopy, NW York University 
Medical Center, 550 First Avenue, New York, NY 10016. USA. 
Corr~,~porufencc uddress: J.M. Pawelek, Department of Dermatology, 
Yale University School of Medicine. 333 Ccdx Street (500 LCI), New 
Haven, CT 065 IO. Fax: (I) (203) 785-7637. 
126 
agreement hat the isomerization of dopachrome to 
DHlCA occurs through a tautomerization reaction and 
that the most appropriate name for DCF thus appears 
to be ‘dopachrome tautomerase’ (DT) (EC 5.3.2.3), the 
term used throughout tllis report [lo-121. 
Since in a test tube metal ions and a melanocyte. 
associated enzyme can each catalyze the tautomcriza- 
rion of dopachrome to DHICA, how is this step regu- 
lated in vivo’? From the data reviewed above there are 
5 possibilities: (i) exclusively by metal ions; (ii) exclu- 
sively by DT; (iii) by DT and separately by metal ions 
(i.e. DT is a metailoenzyme); (iv) by DT in conjunction 
with metal ions; and (v) none of the above (i.e. by an 
as yet undiscovered mechanism). 
In this report we present evidence suggesting that DT 
is a metalloenzyme with ferrous iron at its active site. 
Furthermore, we show that DT has the properties of a 
glycoprotein. Our results are consistent with the recent 
discoveries by Tsukamoto, Jackson, Hearing et a!. that 
DT is part of the tyrosinase-related gene family and 
contains putative iron-binding sites and glycosylated 
domains 113-l 51. Together, these observations could 
reconcile the evidence regarding ‘metal vs. enzyme’ in 
the biological conversion of dopachrome to DHICA [9]. 
2. MATERIALS AND METHODS 
Dopachromc was synthesized by mixing ice-cold t.-dopa (0.75 mg/ 
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Table I Table II 
Effects ol’chclators on tyrosinilsc and DT activities* ET&s orphcnanthrolinc analogs and iron-complcxcd phcnanthroiinc 
on DT activity* 
Chelators mM Tvrosin;isc 
uciivity (6) 
Dopachromc 
t;~ulomerilsc 
ilctivily (%) 
Treutmcnt Dopachrome tautomerasc activity 
(8 corm 01) 
None 100 f I8 100 23 
EDTA 10.0 IG!: 5 99 2 2 
EGTA IO.0 84 & 21 IO’rt 2 
Phcnylthiourm 0.5 I to,1 99 2 2 
2,3-Dihydroxy- 
bcnzoic ncid 20.0 99?I II 11+2 
2,2’-Dipyridyl 20.0 lO6? 6 4425 
I ,IO-Phcnanthrolinc 0. I 99+ I5 71 27 
0,5 N.D. 69 f I 
20.0 96i I5 41 ?:4 
Defcroxaminc 0.1 113 ? I! 95 ?: I 
1.0 96+ I 100 i: 2 
*Incubation conditions are described in Materials and Methods. Rc- 
suits represent avcragc + SC. oftriplicutc snmplcs. The cxpcrimcnts 
were repuatcd scvcrel times with similar results. 
None lOOk I 
1.10.Phcnanthrolinc JR t 3 
I, IO-Phcnanthrolinc-Fe?’ 
(prc-complcxcd) 89 +6 
1.7.Phcnanthrolinc 80 16 
4,7-Phciianlhroliiic 89 c I 
*The crrccis of I .IO-phcnanthrolinc, iron-complcxcd I.lO.phcnan- 
throlinc. ml the non.chclaiing 1.7. and 4.7Gomcrs oi’ l,IQphcnan- 
throlinc on DT activity. All ilgunts were used al concentrations of 
IO IIIM. DT was incubutcd with or without additions for I h. 37°C. 
dialyzed cxhaustivcly. and ussuycd for activity. Results represent 
avcragc 2 S.D. or triplicdtc determinations. The experiments were 
rcpcutcd 3 times with simililr results. 
ml) in sodium phospb~c (0. I M, pH 6.8) with solid Ag,O (30 mg Ag20 
: I nig I.-dopn) Ibr I min und then liltcring ~hc mixture twicr! lhrough 
Gclman Acrodisc Disposnblo Filters (#4192, 0.7 pm di;lnicwr port). 
The resulting or;lngc.rcd solution ol’ dopechronic contzincd about 
33% residual L-dopn. although this had no infiucncr: on LX uctivky 
171. 
DT and tyrosinasc wcrc prcparcd from cultured Cloudmun IIIOUSC 
mclanomu cells 
a 600.fold 
a X0-l‘old increase in the specific activities ol’ both cnzymcs. 
DT activity WIS assayed spcctropho~onrc~rically 3s ~hc conversion 
ol’ dopachronic to DHICA at 475 nm [I]. 
Tyrosinusc activity wus mcusurcd us the formation of “Ii20 liom 
3.5.[“Hltyrosinc by a modification or 111~ method ol’ Pomcruntz [ 161, 
Protein content wus measured using the Picrcc Protein Assay Kit 
(Rockford, IL). with bovine strum albumin as a stimdard. based on 
ihe method ol’ Bradford [ 171. 
Neururninidasc (I’rom Vihriu clro/w~c) and tunicamycin wcrc ob* 
taincd rrom Sigma Chcmic;lls. Ethylcncglycol-bis-(p-amino-ethyl 
othcr)N,N’-tctra-acetic acid (EGTA); 2.2’-dipyridyl: 2,3-dihydroxy 
benzoic acid: phcnanthrolinc-Fc(ll) complex; und I.lO-phcnanthro- 
line wcrc obtained from Sigma Chcmlcal Co.. St. Louis, MO. l,7- 
phcnanthrolinc and 4.7-phcnunthroliilu wcrc obtained from Aldrich 
Chcmiculs, Milwaukee, WI. Phenylthiourcu (PTU) was obtuincd lYoni 
Eastman Kodak Co,, Rochester. NY, Ethyluncdiamine tctraacctic 
acid (EDTA) was u’utaincd from J.T. Baker Chemical Co.. Phil- 
lipsburg, NJ. Dcferoxuminc Was obtained I’rom CIBA-Geigy Corp., 
Summit. NJ. Stock solutions were rnodc YS 0.1 34, cxccpl for PTU 
which was made as 0.01 M in 50% ethanol. 
same incubation conditions the activity of tyrosinase 
was unaffected by these compounds (Fig. 1, Table I). 
On the other hand. tyrosinase was strongly inhibited by 
phcnylthiourea. nd to a lesser extent by EDTA, while 
these compounds had no affect on DT activity. Defer- 
oxuminc. which preferentially complexes ferric ion, had 
no effects on DT activity. however deferoxamine could 
not be used over a wide concentration range because its 
red color obscured the DT assay. The I ,7- and 4,7- 
structural analogs on 1. IO-phenanthroline were only 
weakly inhibitory to DT. consistent with their reduced 
ability to &elate ferrous iron. In addition, the inhib- 
itory effects of I, IO-phcnanthroline on DT were largely 
overcome when the chelator was pre-complexed to fer- 
rous iron (Table II). Finally, inhibition of DT by the 
chelators 2,2’ -dipyridyl and I .lO-phenanthroline was 
reversible by ferrous iron after the chelators were re- 
moved by dialysis (Table III). 
It is well established that tyrosinase is a glycoprotein. 
and evidence has also been presented that the same is 
Tliblc Ill 
Activation or chelated DT by rcrrous iron* 
Incubation with chelators was us follows: purtially purified DT 
(IO-20 yg protein) WBS incubated with chelators (0.1-20 mM) or 
appropriate solvent blanhs Ibr 30 min ut 37°C in B total volume or300 
pl* 
All assays were perrormcd in tripliciltc and rcpcatcd several times. 
3. RESULTS AND DISCUSSION 
The activity of partially purified DT was decreased 
by the iron chelators 2,2’-dipyridyl, 1, IO-phenanthro- 
line, and 2,3-dihydroxybenzoic a id, whereas under the 
Chelator Addition following DT activity 
dialysis (46 control) 
2.?-Dipyridyl None 5? 13 
FCC& 86 +4 
I. IO-Phcnanthrolinc None 36 2 5 
FcCI: 89 2 4 
* DT was incubdlcd with the dcsignatcd chelator (IO mM. 1 h. 37”C), 
dialyzed cxhaustivcly. incubated with FCC& (5 mM. I h. ZO’C). 
dialyzed again. WA ussaycd Tar activity. Control preparationsof DT 
wcrc trcalcd in the: siunc manner without the additions oichciaLors 
or t’cr:ous iron. Rcsuhs represent avcrdge 2 SD. of triplicalc detcr- 
minntions. The cxpcrimunts were rcpcatcd 3 timcx with similar rem 
suits. 
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Fig. 1. ECTects of2,2’-dipyridyl and l.lO-phenanthroline on lyrosinase 
(0) and dopachrome tautomerasc (8) activities. Incubation conditions 
und enzyme ussays ure described in Materials and Methods. Results 
represent average + S.D. of triplicate determinations. The experiments 
were repeucd several times with similar results. 
true for DT [18-201. Our evidence for the glycosylatcd 
nature of DT is as follows: (i) DT adhere to wheat germ 
agglutinin and could be eluted with N-acetylglucosam- 
ine with a recovery of approximately 30% of starting 
material; (ii) treatment of intact Cloudman melanoma 
cells with tunicamycin (0.2 mg/ml culture medium for 
24 h), an inhibitor of N-glycosylation, inhibited both 
tyrosinase (44% of control) and DT (22% of control) 
activities in broken cell preparations; (iii) treatment of 
partially purified DT and tyrosinase with neuram- 
inidase (0.05 mglml, 2 h, 37°C). which hydrolyzes termi- 
nal sialic acid residues from glycoconjugates (glycopro- 
teins, glycolipids), inhibited tyrosinase activity (43% of 
control) and stimulated DT activity, (157% of control). 
Stimulation of DT activity by neuraminidase was also 
reported by Solano et al. [20]. 
The results suggest hat iron, possibly in its ferrous 
(Fe(R)) state, is important for the function of DT, and 
that DT is a glycoprotcin. This evidence is substantiated 
by the genetic analyses of Tsukamoto, Jackson, Hearing 
et al. which show that DT contains both potential iron 
binding sites and glycosylated domains [13-151. 
Whether or not DT actually contains iron and sugars 
remains to be demonstrated. Similarly, direct proof for 
the involvement of iron in the catalytic tautomerization 
of dopachrome awaits further experimentation, since 
little is known regarding the reaction mechanism. None- 
theless, our results suggest hat DT functions as a fer- 
rous iron-binding glycoprotein and provide direction 
for future research into this import new aspect of the 
regulation of melanogenesis [l I]. 
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